Sort
38,696 grants matching “als”
Understanding mechanism and therapy of ALS using RNAi
$359,047Zuoshang Xu · Univ Of Massachusetts Med Sch Worcester · R01 · FY2006 · NS
Role of autophagy and lipid metabolism in organismal aging
$359,043Malene Hansen · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2013 · AG
Defects of mitochondrial dynamics in ALS
$359,026Giovanni Manfredi · Weill Medical Coll Of Cornell Univ · R01 · FY2012 · NS
New Quantitative Neuroimaging Metrics of Structural and Functional Connectivity of the Locus Coeruleus as a Novel Biomarker of Alzheimer's Disease Pathogenesis and Progression
$358,977Lawrence R. Frank · University Of California, San Diego · R01 · FY2021 · AG
EFFECTIVE LOW POWER GAS-LIQUID SEPARATION SYSTEMS ARE IMPERATIVE FOR THE OPERATION OF COST-EFFECTIVE TWO-PHASE FLOW SYSTEMS IN SPACE. THE LIMITATIONS ON THE VOLUMES AND WEIGHTS TO BE CARRIED FOR SPACE EXPERIMENTS MAKE IT IMPERATIVE TO HAVE THE CAPABILITY TO SEPARATE GASES FROM LIQUIDS IN ORDER TO RECYCLE AND REUSE BOTH. ONE EFFECTIVE WAY TO DO SO IS TO USE CENTRIFUGAL FORCE. MANY PHASE SEPARATORS DEVICES HAVE BEEN DESIGNED AND INVESTIGATED USING THIS FORCE AND PASSIVE SEPARATORS REQUIRING NO MOVING MECHANICAL PARTS AND LOW POWER HAVE BEEN INVESTIGATED INTENSIVELY OWING TO THEIR SIMPLICITY AND DEPENDABILITY. MCQUILLEN ET AL. [1-3] AT NASA GLENN RESEARCH CENTER HAS DEVELOPED THE CASCADE CYCLONIC SEPARATION DEVICE (CSD-C). THIS FREE VORTEX SEPARATOR (FVS) IS VERY EFFICIENT FOR MID-RANGE VOID FRACTION (FROM 40 TO 80% OF GAS) WITH AN EFFICIENCY APPROACHING 100%. HOWEVER IT IS NOT AS EFFICIENT FOR LOWER VOID FRACTION.
$358,975Dynaflow, Inc. · · FY2020 · National Aeronautics and Space Administration
Cytomegalovirus Gene Expression and Strain Variability in Glioma Pathogenesis
$358,965Liliana Soroceanu · California Pacific Med Ctr Res Institute · R01 · FY2013 · NS
Multi-Scale Cortical Dynamics in Human Epilepsy
$358,933Wilson Truccolo · Brown University · R01 · FY2021 · NS
Targeting gamma-secretase activation for anti-angiogenesis
$358,925Michael Edwin Boulton · University Of Florida · R01 · FY2008 · EY
NAAG Peptidase and Neuronal Function
$358,900Georgetown University · R01 · FY2005 · NS
Identification of Novel Drugs that Counter Huntington's Disease
$358,897Robert M. Friedlander · Brigham And Women'S Hospital · R01 · FY2007 · NS
Retinyl Ester Binding Proteins and the Visual Cycle
$358,850Robert R Rando · Harvard Medical School · R01 · FY2007 · EY
Project 1 - Nuclear Gene Expression
$358,793Blanton Smith Tolbert · University Of Michigan At Ann Arbor · U54 · FY2020 · AI
Yeast as a gateway to conquering protein misfolding diseases.
$358,780Susan W. Liebman · University Of Nevada Reno · R35 · FY2023 · GM
Stress and Memory Formation Across the Female Lifespan
$358,780Rutgers The St Univ Of Nj New Brunswick · R01 · FY2003 · MH
Yeast as a gateway to conquering protein misfolding diseases.
$358,777Susan W. Liebman · University Of Nevada Reno · R35 · FY2022 · GM
Yeast as a gateway to conquering protein misfolding diseases.
$358,777Susan W. Liebman · University Of Nevada Reno · R35 · FY2024 · GM
Yeast as a gateway to conquering protein misfolding diseases.
$358,757Susan W. Liebman · University Of Nevada Reno · R35 · FY2021 · GM
Mechanisms & Mouse Models of Amyotrophic Lateral Sclerosis
$358,750Philip C Wong · Johns Hopkins University · R01 · FY2009 · NS
Mechanisms & Mouse Models of Amyotrophic Lateral Sclerosis
$358,750Philip C Wong · Johns Hopkins University · R01 · FY2008 · NS
Regulation of Neuronal Lipid Homeostasis By Thioesterases
$358,750Michael J. Wolfgang · Johns Hopkins University · R01 · FY2011 · NS
MOUSE MODEL FOR SICKLE CELL DISEASE &GENETIC THERAPIES
$358,750University Of Alabama At Birmingham · R01 · FY2002 · HL
Mechanism of Selective Toxicity of SOD1 Mutants in ALS
$358,750University Of Alabama At Birmingham · R01 · FY2001 · NS
MOUSE MODEL FOR SICKLE CELL DISEASE &GENETIC THERAPIES
$358,750University Of Alabama At Birmingham · R01 · FY2001 · HL
MOUSE MODEL FOR SICKLE CELL DISEASE &GENETIC THERAPIES
$358,750University Of Alabama At Birmingham · R01 · FY2000 · HL
Skeletal Muscle Mechanisms of Disease in ALS
$358,750Lee J Martin · Johns Hopkins University · R01 · FY2010 · NS